WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Reliability of Pupil Response to Acute Pain

Recruiting

Conditions: Pain
Osteoarthritis

First Posted Date: 2015-12-11

Last Posted Date: 2024-06-28

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 80

Registration Number: NCT02628314

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer

Phase 2

Terminated

Conditions: Urethral Neoplasms
Ureteral Neoplasms
Urinary Bladder Neoplasms

Interventions: Drug: Crizotinib

First Posted Date: 2015-11-23

Last Posted Date: 2022-11-03

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 8

Registration Number: NCT02612194

Locations: 🇺🇸
Levine Cancer Institute, Charlotte, North Carolina, United States

Static Magnetic Therapy for Carpal Tunnel Syndrome

Not Applicable

Completed

Conditions: Carpal Tunnel Syndrome

Interventions: Device: Strong Magnetic Wristband
Device: Weaker Magnetic Wristband

First Posted Date: 2015-11-20

Last Posted Date: 2018-09-10

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 22

Registration Number: NCT02609113

Locations: 🇺🇸
Wake Forest Baptist Health, Winston-Salem, North Carolina, United States

Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients

Not Applicable

Terminated

Conditions: HIV
Aging
Sarcopenia
Angiotensin Receptor Antagonists

Interventions: Other: Placebo
Drug: valsartan

First Posted Date: 2015-11-17

Last Posted Date: 2018-08-28

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 1

Registration Number: NCT02606279

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Inpatient Physical Activity Function Through Enhanced Participation Levels in Animal-Assisted Therapy Programs

Not Applicable

Withdrawn

Conditions: Parkinson's Disease
Muscle Weakness
Stroke

Interventions: Behavioral: Standard of Care Physical Therapy
Behavioral: Canine Animal-Assisted Therapy

First Posted Date: 2015-11-17

Last Posted Date: 2024-10-02

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT02606006

Locations: 🇺🇸
Aurora Sinai Medical Center, Milwaukee, Wisconsin, United States

Comprehensive Post-Acute Stroke Services

Not Applicable

Completed

Conditions: Stroke
Transient Ischemic Attack

Interventions: Other: COMPASS Intervention

First Posted Date: 2015-10-28

Last Posted Date: 2021-06-11

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 6024

Registration Number: NCT02588664

Locations: 🇺🇸
Novant Health Presbyterian Medical Center, Charlotte, North Carolina, United States
🇺🇸
CHS Stanly, Albemarle, North Carolina, United States
🇺🇸
Duke Raleigh Hospital, Raleigh, North Carolina, United States

and more 37 locations

Trial of Acupuncture for Radiation-Induced Xerostomia in Head and Neck Cancer

Not Applicable

Completed

Conditions: Radiation Toxicity
Oral Complications of Chemotherapy and Head/Neck Radiation
Radiation-Induced Xerostomia
Head and Neck Cancer

Interventions: Other: Standard Oral Hygiene + Sham Acupuncture
Other: Standard Oral Hygiene
Other: Standard Oral Hygiene + True Acupuncture

First Posted Date: 2015-10-28

Last Posted Date: 2022-11-04

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 230

Registration Number: NCT02589938

Locations: 🇺🇸
Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States
🇺🇸
Physicians' Clinic of Iowa PC, Cedar Rapids, Iowa, United States
🇺🇸
Saint Luke's Hospital, Cedar Rapids, Iowa, United States

and more 33 locations

Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery

Phase 1

Completed

Conditions: Metastatic Malignant Neoplasm
Advanced Malignant Neoplasm
Unresectable Malignant Neoplasm

Interventions: Diagnostic Test: Laboratory Biomarker Analysis
Drug: Muscadine Grape Skin Extract
Procedure: Quality-of-Life Assessment

First Posted Date: 2015-10-22

Last Posted Date: 2023-06-05

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 24

Registration Number: NCT02583269

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Paclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial Cancer

Phase 2

Completed

Conditions: Transitional Cell Carcinoma

Interventions: Other: Laboratory Biomarker Analysis
Drug: Paclitaxel
Biological: Pembrolizumab

First Posted Date: 2015-10-21

Last Posted Date: 2023-01-10

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 27

Registration Number: NCT02581982

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung Cancer

Phase 2

Completed

Conditions: Recurrent Non-Small Cell Lung Carcinoma
Stage IIIB Non-Small Cell Lung Cancer
Stage IV Non-Small Cell Lung Cancer

Interventions: Other: Laboratory Biomarker Analysis
Drug: Carboplatin
Biological: Pembrolizumab
Other: Quality-of-Life Assessment
Drug: Paclitaxel

First Posted Date: 2015-10-21

Last Posted Date: 2024-01-05

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 43

Registration Number: NCT02581943

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy